Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Total Occlusion of Coronary Artery
- Sponsor
- Kurashiki Central Hospital
- Enrollment
- 19000
- Locations
- 1
- Primary Endpoint
- successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up
- Status
- Recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients eligible for PCI
- •Patients who underwent PCI for CTO lesions that contain the following:
- •Thrombolysis in myocardial infarction trial (TIMI) 0
- •The occlusive period more than 3 months or unknown
- •The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Exclusion Criteria
- •Patients ineligible for PCI judged in clinical practice
Outcomes
Primary Outcomes
successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up
Time Frame: within the first 1 month (plus 1 month) after PCI and during the 5-year follow-up
early and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan